On June 20, 2024, Mr. Chih Young Hung notified International Media Acquisition Corp. (the “Company”) that he is resigning from the board of directors (the “ Board ”) of the Company effective immediately.
On June 20, 2024, Kenneth "Chip" Virnig notified the Board of Directors (the “Board”) of Dynatrace, Inc. (the “Company”) of his resignation from the Board, effective as of July 31, 2024.
On June 25, 2024, the Board of Directors of HNI Corporation (the “Corporation”) elected David Roberts as a director of the Corporation, to serve an initial term expiring at the Corporation’s 2025 annual meeting of shareholders .
On June 19, 2024, Mauricio F. Riveros tendered his resignation from the Board of Directors (the “Board”) of Financial Institutions, Inc. (the “Company”) and as a member of the Board of Five Star Bank effective immediately.
Effective June 21, 2024, by resolution of the board of directors of the Company, Dr. Samuel L. Barker was appointed Chair of the board of directors to replace Dr. Christopher Henney, who requested to step down as Chair but will continue as a director of the Company.
On June 24 , 2024, the Board of Directors (the “Board”) of NextNav Inc. (the “Company”), following the recommendation of the Nominating and Corporate Governance Committee of the Board, increased the size of the Board from six (6) directors to seven (7) directors and appointed Nicola Palmer as a director to fill the resulting vacancy with her term expiring at the Company’s 202 5 annual meeting of stockholders and until her successor has been elected and qualified, subject, however, to her earlier death, resignation, retirement, disqualification or removal.
Prateek Gattani, Chairman of the Board, Robert Machinist, Vice Chairman of the Board, Jeffrey Jagid, Jeffrey Kurtz and David Solimine were elected to the Board joining David Pfeffer
Prateek Gattani, Chairman of the Board, Robert Machinist, Vice Chairman of the Board, Jeffrey Jagid, Jeffrey Kurtz and David Solimine were elected to the Board joining David Pfeffer
Prateek Gattani, Chairman of the Board, Robert Machinist, Vice Chairman of the Board, Jeffrey Jagid, Jeffrey Kurtz and David Solimine were elected to the Board joining David Pfeffer
Effective June 25, 2024, the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”) increased the size of the Board to 12 directors and, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Thomas N. Bohjalian to serve as a director.
On June 24, 2024, Oak Valley Bancorp issued a press release announcing that Ronald C. Marrtin will be retiring as a director of Oak Valley Bancorp and of its wholly owned subsidiary Oak Valley Community Bank effective June 30, 2024.
On June 23, 2024, the board of directors (the "Board") of ThredUp Inc. (the "Company") appointed Noam Paransky to the Board as a Class III director, effective as of June 23, 2024.
On June 19, 2024, Alexander Coleman notified the Board of Directors (the “Board”) of AST SpaceMobile, Inc. (the “Company”) of his decision to resign from the Board, effective on the same date.
On June 19, 2024, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Christopher Sambar as a director, effective June 20, 2024, to fill the vacancy on the Board created by Mr. Coleman’s resignation.
Departed
Roger Nielsen
Director
CQENS Technologies Inc.
Effective
2024-06-24
Filed
June 25, 2024, 7:59 PM ET
On June 24, 2024, CQENS Technologies Inc. (the “Company”) reported the death of Roger Nielsen, the secretary of the Company and a member of the Company’s board of directors.
On June 19, 2024, the Board of Directors (the “Board”) of PHINIA Inc. (the “Company”) increased the size of the Board from seven to eight members and elected Meggan M. Walsh to fill the resulting vacancy, each effective July 1, 2024 (the “Effective Date”).
On June 20, 2024, the Board of Directors (the “Board”) of Frontier Group Holdings, Inc. (the “Company”) appointed Nancy Lipson to serve as a Class I director, effective as of July 1, 2024
Joseph G. Flanagan, a member of the Board of Directors (the “Board”) of GoHealth, Inc. (the “Company”), informed the Company of his intent to resign from the Board effective June 25, 2024.
On June 20, 2024, the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”) approved the appointment of Leah A. Solivan to serve as a director of the Company beginning June 24, 2024.
Appointed
Craig R. Jalbert
sole member of the Board
eFFECTOR Therapeutics, Inc.
Effective
2024-06-21
Filed
June 24, 2024, 7:59 PM ET
On June 21, 2024, the Board appointed Craig R. Jalbert, age 62, as the Company’s CEO, President, Treasurer and Secretary, and sole member of the Board.
Departed
Elizabeth P. Bhatt
Director
eFFECTOR Therapeutics, Inc.
Effective
2024-06-21
Successor
Craig R. Jalbert
Filed
June 24, 2024, 7:59 PM ET
On June 21, 2024, in connection with the planned wind down of the Company’s operations, Brian M. Gallagher, Jr., Ph.D., Elizabeth P. Bhatt, Chris Ehrlich, Kristen Harrington-Smith, Barbara Klencke, M.D., Caroline Loewy and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the board of directors
Departed
Stephen T. Worland, Ph.D.
Director
eFFECTOR Therapeutics, Inc.
Effective
2024-06-21
Successor
Craig R. Jalbert
Filed
June 24, 2024, 7:59 PM ET
On June 21, 2024, in connection with the planned wind down of the Company’s operations, Brian M. Gallagher, Jr., Ph.D., Elizabeth P. Bhatt, Chris Ehrlich, Kristen Harrington-Smith, Barbara Klencke, M.D., Caroline Loewy and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the board of directors
Departed
Brian M. Gallagher, Jr., Ph.D.
Director
eFFECTOR Therapeutics, Inc.
Effective
2024-06-21
Successor
Craig R. Jalbert
Filed
June 24, 2024, 7:59 PM ET
On June 21, 2024, in connection with the planned wind down of the Company’s operations, Brian M. Gallagher, Jr., Ph.D., Elizabeth P. Bhatt, Chris Ehrlich, Kristen Harrington-Smith, Barbara Klencke, M.D., Caroline Loewy and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the board of directors
Departed
Chris Ehrlich
Director
eFFECTOR Therapeutics, Inc.
Effective
2024-06-21
Successor
Craig R. Jalbert
Filed
June 24, 2024, 7:59 PM ET
On June 21, 2024, in connection with the planned wind down of the Company’s operations, Brian M. Gallagher, Jr., Ph.D., Elizabeth P. Bhatt, Chris Ehrlich, Kristen Harrington-Smith, Barbara Klencke, M.D., Caroline Loewy and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the board of directors
Departed
Barbara Klencke, M.D.
Director
eFFECTOR Therapeutics, Inc.
Effective
2024-06-21
Successor
Craig R. Jalbert
Filed
June 24, 2024, 7:59 PM ET
On June 21, 2024, in connection with the planned wind down of the Company’s operations, Brian M. Gallagher, Jr., Ph.D., Elizabeth P. Bhatt, Chris Ehrlich, Kristen Harrington-Smith, Barbara Klencke, M.D., Caroline Loewy and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the board of directors
Departed
Caroline Loewy
Director
eFFECTOR Therapeutics, Inc.
Effective
2024-06-21
Successor
Craig R. Jalbert
Filed
June 24, 2024, 7:59 PM ET
On June 21, 2024, in connection with the planned wind down of the Company’s operations, Brian M. Gallagher, Jr., Ph.D., Elizabeth P. Bhatt, Chris Ehrlich, Kristen Harrington-Smith, Barbara Klencke, M.D., Caroline Loewy and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the board of directors
Departed
Kristen Harrington-Smith
Director
eFFECTOR Therapeutics, Inc.
Effective
2024-06-21
Successor
Craig R. Jalbert
Filed
June 24, 2024, 7:59 PM ET
On June 21, 2024, in connection with the planned wind down of the Company’s operations, Brian M. Gallagher, Jr., Ph.D., Elizabeth P. Bhatt, Chris Ehrlich, Kristen Harrington-Smith, Barbara Klencke, M.D., Caroline Loewy and Stephen T. Worland, Ph.D., each notified the Company of their respective resignations as members of the board of directors
Appointed
Michael Cloonan
Class I director
bluebird bio, Inc.
Effective
2024-06-20
Filed
June 24, 2024, 7:59 PM ET
On June 20, 2024, the board of directors (the “Board”) of bluebird bio, Inc. (the “Company”) appointed Michael Cloonan to the Board as a Class I director, effective June 20, 2024.
Effective June 24, 2024, The Goldman Sachs Group, Inc. (the Registrant) appointed John B. Hess as an independent member of the Registrant’s Board of Directors.
William (Bill) Chase, Steve Mizell, Gregory (Greg) Summe and Robert Ragusa were appointed to the Board.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.